Tag: generic drugs

How Generic Drugs Control Healthcare Costs: The Economics of Savings

By : Tamsin Riverton
Date : Jun 19 2026

Discover how generic drugs reduce healthcare spending by 80-85%. Learn about biosimilars, FDA regulations, and the economic impact of generic competition on patient costs.

How Generic Drugs Control Healthcare Costs: A 2026 Guide

By : Tamsin Riverton
Date : Jun 19 2026

Discover how generic drugs cut healthcare costs by 80-85% and dominate 90% of prescriptions. Learn about biosimilars, patent barriers, and real-world savings in this 2026 guide.

Hatch-Waxman Act Explained: How It Changed Generic Drug Prices and Patents

By : Tamsin Riverton
Date : Jun 9 2026

Discover how the Hatch-Waxman Act revolutionized the US pharmaceutical industry by balancing patent protection for innovators with accelerated approval for generic drugs, drastically lowering medication costs.

Do Generic Drugs Have Different Interaction Risks Than Brand Names?

By : Tamsin Riverton
Date : Apr 10 2026

Discover if generic medications carry different drug interaction risks than brand-name drugs. Learn about bioequivalence, inactive ingredients, and safety data.

Employer health plans and generic preferences: navigating coverage

By : Tamsin Riverton
Date : Mar 27 2026

Learn how employer health plans use formularies to control costs, prioritizing generic drugs over brand names. A practical guide to tiers, PBMs, and maximizing your coverage.

Pharmacy Margin Economics: How Generics Affect Profits

By : Tamsin Riverton
Date : Mar 24 2026

Generics make up 90% of prescriptions but only 25% of drug spending - yet they generate 96% of pharmacy profits. How PBMs, consolidation, and pricing models are reshaping pharmacy economics.

NTI-Specific Substitution Laws: Which States Have Special Rules for Critical Medications

By : Tamsin Riverton
Date : Mar 10 2026

Twenty-seven U.S. states have special rules blocking or restricting generic substitutions for narrow therapeutic index (NTI) drugs like warfarin, levothyroxine, and lithium. Here's where substitution is allowed, restricted, or banned - and what it means for patients.

Perception vs Reality: Why Generics Seem Less Effective Than Brand-Name Drugs

By : Tamsin Riverton
Date : Feb 24 2026

Generics are scientifically identical to brand-name drugs, yet many people believe they’re less effective. This article explains why the perception gap exists, how it affects health outcomes, and what you can do about it.

Pharmacokinetic Studies and Generic Drug Equivalence: What You Really Need to Know

By : Tamsin Riverton
Date : Feb 4 2026

Pharmacokinetic studies are commonly called the 'gold standard' for proving generic drugs work the same as brand-name versions. But the reality is more complex. This article explains how these studies actually work, their limitations for certain drugs, and why regulators use multiple testing methods to ensure safety and effectiveness.

Planning for Patent Expiry: What Patients and Healthcare Systems Need to Do Now

By : Tamsin Riverton
Date : Feb 2 2026

Patent expiry means cheaper drugs-but only if you plan ahead. Learn what patients and healthcare systems must do now to avoid disruptions and save money when brand-name medications lose exclusivity.

Global Perspectives on Generics: How Countries Control Drug Costs and What Works Best

By : Tamsin Riverton
Date : Jan 3 2026

Global policies on generic drugs vary widely-from China’s price-cutting auctions to the U.S.’s high-volume market. Discover how different countries balance affordability, quality, and innovation in generic medication access.

Infographics About Generics: Visual Education Tools for Patient Understanding

By : Tamsin Riverton
Date : Dec 10 2025

Infographics about generics help patients understand that generic drugs are just as safe and effective as brand-name versions. With clear visuals, the FDA’s tools explain bioequivalence, manufacturing standards, and cost savings-reducing skepticism and improving adherence.